Cargando…
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
BACKGROUND: We aimed at investigating the outcomes of female patients with stage IIIB-IV adenocarcinoma of the lung according to EGFR and K-Ras mutational status. METHODS: One hundred and three consecutive female patients genotyped at a single Italian Institution were analyzed. Patients were planned...
Autores principales: | Rotella, Virginia, Fornaro, Lorenzo, Vasile, Enrico, Tibaldi, Carmelo, Boldrini, Laura, Chella, Antonio, D’Incecco, Armida, Cirigliano, Giovanna, Chioni, Aldo, Lupi, Cristiana, Sensi, Elisa, Ginocchi, Laura, Giovannelli, Simona, Pennucci, Maria Cristina, Fontanini, Gabriella, Baldini, Editta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198726/ https://www.ncbi.nlm.nih.gov/pubmed/25300933 http://dx.doi.org/10.1186/s13046-014-0077-6 |
Ejemplares similares
-
Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors
por: Tibaldi, Carmelo, et al.
Publicado: (2017) -
Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series
por: Bruno, Rossella, et al.
Publicado: (2021) -
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
por: ALÌ, GRETA, et al.
Publicado: (2015) -
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
por: D'Incecco, A, et al.
Publicado: (2015) -
Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
por: Alì, Greta, et al.
Publicado: (2023)